Results of activities on the safety of medicinal products

Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2026

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the second quarter of 2026, compiled from information from 14 regions of Ukraine. Contains the distribution of the frequency of general, local and other manifestations of adverse reactions by vaccine type, batch and manufacturer. generated automatically

Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2026

Summary data on cases of adverse reactions after the use of vaccines and tuberculin for Q1 2026, generalized from information from 11 regions of Ukraine. Contain tables of the frequency of general, local and other manifestations of AR by vaccine type and number of immunized persons. compiled automatically

Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2025

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the fourth quarter of 2025, compiled from information from 12 regions of Ukraine. Contains the distribution of the frequency of general, local, and other manifestations of adverse reactions by vaccine type and number of immunized persons. generated automatically

Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2025

Summary data of the Pharmacovigilance Department on cases of adverse reactions after use of vaccines and tuberculin for the third quarter of 2025, summarized from information from 11 regions of Ukraine. Contain the distribution of the frequency of general, local, and other manifestations of ARs by vaccine type, batch, manufacturer, and number of immunized persons. compiled automatically

Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2025

Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2025

Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2024

Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2024

Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2024

Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2024